DOCS logo

Dr. Martens plc Stock Price

LSE:DOCS Community·UK£673.7m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 33 Fair Values set on narratives written by author

DOCS Share Price Performance

UK£0.70
0.70 (0.00%)
UK£1.41
Fair Value
UK£0.70
0.70 (0.00%)
50.6% undervalued intrinsic discount
UK£1.41
Fair Value
Price UK£0.70
AnalystHighTarget UK£1.41
AnalystLowTarget UK£0.80
AnalystConsensusTarget UK£1.05

DOCS Community Narratives

·
Fair Value UK£1.41 50.6% undervalued intrinsic discount

Asian DTC Markets And Digital Retail Will Expand Global Reach

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value UK£0.8 13.0% undervalued intrinsic discount

High Valuations Will Suffer Rising Supply Costs And Consumer Shifts

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value UK£1.05 33.7% undervalued intrinsic discount

Cost Savings Ahead Of Schedule Will Improve Profitability By FY '26

0users have liked this narrative
0users have commented on this narrative
18users have followed this narrative
UK£1.41
50.6% undervalued intrinsic discount
Revenue
4.38% p.a.
Profit Margin
11.1%
Future PE
18.93x
Price in 2029
UK£1.93
UK£0.8
13.0% undervalued intrinsic discount
Revenue
4.16% p.a.
Profit Margin
8.3%
Future PE
14.3x
Price in 2029
UK£1.08
UK£1.05
33.7% undervalued intrinsic discount
Revenue
4.02% p.a.
Profit Margin
7.07%
Future PE
21.74x
Price in 2028
UK£1.4

Trending Discussion

Updated Narratives

DOCS logo

DOCS: Future Returns Will Depend On Steady Margins And Long Term Assumptions

Fair Value: UK£1.41 50.6% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
DOCS logo

DOCS: Future Returns Will Rely On Margins And Long Term Sustainability Partnership

Fair Value: UK£0.8 13.0% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
DOCS logo

Cost Savings Ahead Of Schedule Will Improve Profitability By FY '26

Fair Value: UK£1.05 33.7% undervalued intrinsic discount
18 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

2 Risks
3 Rewards

Dr. Martens plc Key Details

UK£764.9m

Revenue

UK£258.9m

Cost of Revenue

UK£506.0m

Gross Profit

UK£482.2m

Other Expenses

UK£23.8m

Earnings

Last Reported Earnings
Mar 29, 2026
Next Reporting Earnings
n/a
0.025
66.15%
3.11%
69.1%
View Full Analysis

About DOCS

Founded
1945
Employees
2377
CEO
Onyeije Nwokorie
WebsiteView website
www.drmartensplc.com

Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Recent DOCS News & Updates

Narrative Update May 13

DOCS: Future Returns Will Depend On Steady Margins And Long Term Assumptions

Analysts have adjusted their price views on Dr. Martens, reflecting updated assumptions around discount rates, modestly different revenue growth and profit margin expectations, and a slightly altered future P/E multiple. Together, these factors feed into a refreshed £1.41 fair value estimate.

Recent updates

No updates